| Product Code: ETC7549471 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Oncology Companion Diagnostic Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Oncology Companion Diagnostic Market Revenues & Volume, 2021 & 2031F |
3.3 India Oncology Companion Diagnostic Market - Industry Life Cycle |
3.4 India Oncology Companion Diagnostic Market - Porter's Five Forces |
3.5 India Oncology Companion Diagnostic Market Revenues & Volume Share, By Product & Service, 2021 & 2031F |
3.6 India Oncology Companion Diagnostic Market Revenues & Volume Share, By Technology(Revenue, USD Million, 2021-2031), 2021 & 2031F |
3.7 India Oncology Companion Diagnostic Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.8 India Oncology Companion Diagnostic Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 India Oncology Companion Diagnostic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer cases in India |
4.2.2 Growing awareness about personalized medicine and companion diagnostics |
4.2.3 Advancements in diagnostic technologies and techniques |
4.3 Market Restraints |
4.3.1 High cost associated with companion diagnostic tests |
4.3.2 Regulatory challenges and approval processes |
4.3.3 Limited accessibility to advanced diagnostic facilities in rural areas |
5 India Oncology Companion Diagnostic Market Trends |
6 India Oncology Companion Diagnostic Market, By Types |
6.1 India Oncology Companion Diagnostic Market, By Product & Service |
6.1.1 Overview and Analysis |
6.1.2 India Oncology Companion Diagnostic Market Revenues & Volume, By Product & Service, 2021- 2031F |
6.1.3 India Oncology Companion Diagnostic Market Revenues & Volume, By Product, 2021- 2031F |
6.1.4 India Oncology Companion Diagnostic Market Revenues & Volume, By Service, 2021- 2031F |
6.2 India Oncology Companion Diagnostic Market, By Technology(Revenue, USD Million, 2021-2031) |
6.2.1 Overview and Analysis |
6.2.2 India Oncology Companion Diagnostic Market Revenues & Volume, By Polymerase chain reaction (PCR), 2021- 2031F |
6.2.3 India Oncology Companion Diagnostic Market Revenues & Volume, By Next-generation sequencing (NGS), 2021- 2031F |
6.2.4 India Oncology Companion Diagnostic Market Revenues & Volume, By Immunohistochemistry (IHC), 2021- 2031F |
6.2.5 India Oncology Companion Diagnostic Market Revenues & Volume, By In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH), 2021- 2031F |
6.2.6 India Oncology Companion Diagnostic Market Revenues & Volume, By Other technologies, 2021- 2031F |
6.3 India Oncology Companion Diagnostic Market, By Type |
6.3.1 Overview and Analysis |
6.3.2 India Oncology Companion Diagnostic Market Revenues & Volume, By Breast cancer, 2021- 2031F |
6.3.3 India Oncology Companion Diagnostic Market Revenues & Volume, By Non-small cell lung cancer, 2021- 2031F |
6.3.4 India Oncology Companion Diagnostic Market Revenues & Volume, By Colorectal cancer, 2021- 2031F |
6.3.5 India Oncology Companion Diagnostic Market Revenues & Volume, By Leukemia, 2021- 2031F |
6.3.6 India Oncology Companion Diagnostic Market Revenues & Volume, By Melanoma, 2021- 2031F |
6.3.7 India Oncology Companion Diagnostic Market Revenues & Volume, By Prostate cancer, 2021- 2031F |
6.4 India Oncology Companion Diagnostic Market, By End Use |
6.4.1 Overview and Analysis |
6.4.2 India Oncology Companion Diagnostic Market Revenues & Volume, By Hospital, 2021- 2031F |
6.4.3 India Oncology Companion Diagnostic Market Revenues & Volume, By Pathology/Diagnostic laboratory, 2021- 2031F |
6.4.4 India Oncology Companion Diagnostic Market Revenues & Volume, By Academic medical center, 2021- 2031F |
7 India Oncology Companion Diagnostic Market Import-Export Trade Statistics |
7.1 India Oncology Companion Diagnostic Market Export to Major Countries |
7.2 India Oncology Companion Diagnostic Market Imports from Major Countries |
8 India Oncology Companion Diagnostic Market Key Performance Indicators |
8.1 Adoption rate of companion diagnostic tests in oncology treatments |
8.2 Research and development investments in oncology companion diagnostics |
8.3 Number of collaborations between diagnostic companies and healthcare providers |
8.4 Rate of integration of companion diagnostics in standard cancer treatment protocols |
9 India Oncology Companion Diagnostic Market - Opportunity Assessment |
9.1 India Oncology Companion Diagnostic Market Opportunity Assessment, By Product & Service, 2021 & 2031F |
9.2 India Oncology Companion Diagnostic Market Opportunity Assessment, By Technology(Revenue, USD Million, 2021-2031), 2021 & 2031F |
9.3 India Oncology Companion Diagnostic Market Opportunity Assessment, By Type, 2021 & 2031F |
9.4 India Oncology Companion Diagnostic Market Opportunity Assessment, By End Use, 2021 & 2031F |
10 India Oncology Companion Diagnostic Market - Competitive Landscape |
10.1 India Oncology Companion Diagnostic Market Revenue Share, By Companies, 2024 |
10.2 India Oncology Companion Diagnostic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here